Brigitte Guérin Selected Research

Brigitte Guérin Research Topics

Disease

30	Neoplasms (Cancer) 02/2023 - 03/2009
13	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 02/2012
7	Breast Neoplasms (Breast Cancer) 10/2020 - 02/2010
6	Glucose Intolerance 01/2022 - 11/2012
4	Insulin Resistance 01/2022 - 01/2020
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2016
4	Prediabetic State (Prediabetes) 01/2022 - 01/2020
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 02/2011
3	Overweight 01/2022 - 11/2012
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2022
2	Metabolic Diseases (Metabolic Disease) 01/2022 - 12/2020
2	Inflammation (Inflammations) 10/2021 - 04/2019
2	Neoplasm Metastasis (Metastasis) 06/2020 - 04/2019
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018 - 01/2017
2	Weight Loss (Weight Reduction) 11/2015 - 06/2014
1	Cognitive Dysfunction 12/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 11/2021
1	Glioma (Gliomas) 11/2021
1	Obesity 01/2021
1	Adenocarcinoma 08/2017
1	Rectal Neoplasms (Rectal Cancer) 01/2016
1	Left Ventricular Dysfunction 11/2015
1	Carcinoma (Carcinomatosis) 08/2014
1	Abdominal Obesity 11/2012

Drug/Important Bio-Agent (IBA)

12	Peptides (Polypeptides)IBA 01/2019 - 08/2011
11	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 02/2011
9	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2022 - 08/2011
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2011
5	margaric acid (heptadecanoic acid)IBA 01/2022 - 02/2011
5	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2019 - 08/2014
5	Bombesin Receptors (Bombesin Receptor)IBA 01/2018 - 08/2011
4	Estrogen ReceptorsIBA 01/2022 - 08/2017
4	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 02/2011
4	AcidsIBA 01/2021 - 08/2014
3	11-methoxy-4,16-difluoroestradiolIBA 01/2022 - 06/2020
3	Chelating AgentsIBA 10/2021 - 08/2011
3	Insulin (Novolin)FDA Link 01/2021 - 02/2011
3	Radioisotopes (Radionuclides)IBA 12/2020 - 01/2018
2	Copper-64IBA 01/2023 - 08/2014
2	Amyloid (Amyloid Fibrils)IBA 01/2023 - 12/2022
2	IsotopesIBA 01/2022 - 06/2020
2	PalmitatesIBA 01/2022 - 01/2021
2	PlatinumIBA 01/2022 - 08/2021
2	BombesinIBA 01/2018 - 08/2012
2	Dietary Fats (Dietary Fat)IBA 11/2015 - 03/2011
2	14-fluoro-6-thiaheptadecanoic acidIBA 07/2015 - 02/2011
1	DNA (Deoxyribonucleic Acid)IBA 02/2023
1	Lutetium-177IBA 01/2023
1	SolutionsIBA 01/2023
1	gallium Ga 68 dotatateIBA 01/2023
1	AntigensIBA 08/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	SugarsIBA 01/2022
1	HydrogelsIBA 11/2021
1	Chemotactic FactorsIBA 11/2021
1	Freund's AdjuvantIBA 10/2021
1	Citric Acid (Citrate)FDA LinkGeneric 10/2021
1	Glycerol (Glycerine)FDA LinkGeneric 01/2021
1	triazacyclononaneIBA 01/2021
1	IonsIBA 12/2020
1	AntibodiesIBA 06/2020
1	human ERBB2 proteinIBA 06/2020
1	CarbohydratesIBA 01/2020
1	Dinoprostone (PGE2)FDA Link 04/2019
1	alovudineIBA 04/2019
1	Fluorouracil (Carac)FDA LinkGeneric 04/2019
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2019
1	ProdrugsIBA 01/2019
1	AlbuminsIBA 01/2019
1	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2018
1	Cholic AcidIBA 01/2018
1	FurinIBA 08/2017
1	Biomarkers (Surrogate Marker)IBA 08/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Peptide YYIBA 11/2016
1	NeuropeptidesIBA 11/2016
1	Tiopronin (Thiola)FDA Link 01/2016
1	GoldIBA 01/2016
1	PeptidomimeticsIBA 02/2015
1	EnzymesIBA 02/2015
1	peptide AIBA 01/2015
1	Leucine (L-Leucine)FDA Link 08/2014
1	Triglycerides (Triacylglycerol)IBA 06/2014
1	IntegrinsIBA 02/2013
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2013
1	Photosensitizing Agents (Photosensitizers)IBA 02/2013
1	MetalsIBA 08/2012
1	A-factor (Streptomyces)IBA 08/2012

Therapy/Procedure

7	Therapeutics 02/2023 - 01/2017
3	Precision Medicine 01/2023 - 01/2022
2	Cyclotrons 01/2023 - 10/2021
2	Radiotherapy 04/2019 - 08/2014
2	Intravenous Injections 01/2018 - 01/2016
1	Castration 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Bariatric Surgery 01/2020
1	Mastectomy (Mammectomy) 01/2018
1	Oral Administration 06/2014
1	Photochemotherapy (Photodynamic Therapy) 02/2013